Crossmark

Synthesis and Primary Antitumor Screening of 5-Ylidene Derivatives of 3-(Morpholin-4-yl)-2-sulfanylidene-1,3-thiazolidin-4-one

Published Online: 2020-04-22

Published Print: 2020-03

Authors

Horishny, V. Ya.

Chaban, T. I.

Matiychuk, V. S.
License Information

Text and Data Mining valid from 2020-03-01

Version of Record valid from 2020-03-01
More Information

Article History

Received: 11 November 2019

Revised: 18 January 2020

Accepted: 20 January 2020

First Online: 22 April 2020

CONFLICT OF INTEREST

: The authors declare the absence of conflict of interest.

Document is current